These cell‐based data suggest that the airway microenvironment, which drives the formation of different IL33 isoforms, in combination with IL1RL1 nonsynonymous genetic variation, may determine the inflammatory response in specific asthma patients. This evidence concerns the gene IL33 and asthma.